Adirondack Trust Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
8,753
-66
-0.7% -$7.72K 0.34% 62
2026
Q1
$1.06M Sell
8,819
-195
-2% -$22.5K 0.36% 61
2025
Q4
$949K Sell
9,014
-596
-6% -$55.9K 0.31% 65
2025
Q3
$807K Sell
9,610
-218
-2% -$18K 0.27% 72
2025
Q2
$778K Sell
9,828
-412
-4% -$32.7K 0.28% 75
2025
Q1
$919K Sell
10,240
-535
-5% -$50K 0.36% 64
2024
Q4
$1.07M Sell
10,775
-116
-1% -$12K 0.41% 58
2024
Q3
$1.24M Sell
10,891
-196
-2% -$23.3K 0.48% 52
2024
Q2
$1.37M Sell
11,087
-80
-0.7% -$10.3K 0.56% 45
2024
Q1
$1.47M Sell
11,167
-142
-1% -$17.5K 0.62% 44
2023
Q4
$1.44M Sell
11,309
-85
-0.7% -$8.82K 0.62% 43
2023
Q3
$1.17M Sell
11,394
-142
-1% -$15.3K 0.59% 43
2023
Q2
$1.23M Sell
11,536
-351
-3% -$39.9K 0.57% 43
2023
Q1
$1.26M Sell
11,887
-71
-0.6% -$7.67K 0.64% 38
2022
Q4
$1.33M Buy
11,958
+267
+2% +$27.3K 0.69% 33
2022
Q3
$1.01M Buy
11,691
+221
+2% +$19.7K 0.56% 42
2022
Q2
$1.05M Buy
11,470
+802
+8% +$71.1K 0.56% 40
2022
Q1
$876K Buy
10,668
+1,780
+20% +$140K 0.41% 64
2021
Q4
$681K Buy
8,888
+30
+0.3% +$2.39K 0.32% 70
2021
Q3
$780K Sell
8,858
-85
-1% -$6.46K 0.37% 66
2021
Q2
$696K Sell
8,943
-152
-2% -$11.3K 0.35% 68
2021
Q1
$669K Buy
9,095
+1,321
+17% +$97.4K 0.36% 69
2020
Q4
$572K Buy
7,774
+94
+1% +$7.19K 0.34% 64
2020
Q3
$607K Sell
7,680
-26
-0.3% -$2.04K 0.4% 58
2020
Q2
$590K Hold
7,706
0.39% 59
2020
Q1
$565K Sell
7,706
-220
-3% -$17.3K 0.46% 52
2019
Q4
$646K Sell
7,926
-2,290
-22% -$188K 0.42% 51
2019
Q3
$821K Sell
10,216
-852
-8% -$68.3K 0.58% 44
2019
Q2
$886K Hold
11,068
0.62% 43
2019
Q1
$831K Sell
11,068
-320
-3% -$23.9K 0.57% 42
2018
Q4
$830K Buy
11,388
+713
+7% +$50.3K 0.64% 40
2018
Q3
$722K Buy
10,675
+32
+0.3% +$2.04K 0.49% 47
2018
Q2
$617K Sell
10,643
-105
-1% -$5.92K 0.44% 52
2018
Q1
$604K Buy
10,748
+87
+0.8% +$4.7K 0.43% 52
2017
Q4
$572K Sell
10,661
-304
-3% -$16.9K 0.42% 54
2017
Q3
$670K Sell
10,965
-629
-5% -$38.1K 0.53% 50
2017
Q2
$709K Sell
11,594
-284
-2% -$17.3K 0.57% 45
2017
Q1
$720K Buy
11,878
+43
+0.4% +$2.61K 0.5% 51
2016
Q4
$665K Buy
11,835
+358
+3% +$21K 0.46% 55
2016
Q3
$684K Buy
11,477
+252
+2% +$14.7K 0.49% 53
2016
Q2
$617K Sell
11,225
-498
-4% -$26.5K 0.44% 55
2016
Q1
$592K Buy
11,723
+63
+0.5% +$3.09K 0.44% 56
2015
Q4
$563K Buy
11,660
+475
+4% +$23.9K 0.45% 56
2015
Q3
$527K Buy
11,185
+21
+0.2% +$1.12K 0.42% 60
2015
Q2
$607K Buy
11,164
+21
+0.2% +$1.18K 0.45% 54
2015
Q1
$611K Buy
11,143
+235
+2% +$13.3K 0.46% 57
2014
Q4
$591K Buy
10,908
+126
+1% +$7.02K 0.44% 56
2014
Q3
$609K Buy
10,782
+2,226
+26% +$125K 0.46% 52
2014
Q2
$472K Hold
8,556
0.36% 66
2014
Q1
$463K Buy
8,556
+3,903
+84% +$202K 0.37% 65
2013
Q4
$222K Hold
4,653
0.18% 80
2013
Q3
$211K Buy
4,653
+534
+13% +$24.4K 0.19% 81
2013
Q2
$183K Buy
+4,119
New +$184K 0.17% 86

Other funds holding MRK

Adirondack Trust Company's MRK Position: Q2 2026 in Review

Adirondack Trust Company reduced its Merck (MRK) stake by 0.75% in Q2 2026, selling an estimated $7.72K and leaving 8,753 shares worth $1.12M. The position accounts for 0.34% of the portfolio, ranked #62.

Adirondack Trust Company first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.47M in Q1 2024. 1,078 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Adirondack Trust Company held 8,753 shares of Merck worth $1.12M as of Q2 2026.
  • Adirondack Trust Company sold 66 Merck shares in Q2 2026, an estimated $7.72K.
  • Merck made up 0.34% of Adirondack Trust Company's portfolio in Q2 2026, its #62 holding.
  • Adirondack Trust Company first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Adirondack Trust Company's Merck position peaked at $1.47M in Q1 2024.
  • 1,078 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.